I guess this is Vitternomics for prescription drugs. The problem is that even if the U.S. did overwhelm the Canadian system, there are still plenty of other countries around the world with similar programs. The end result is likely to be higher prices in Canada, and no change in the U.S.
Besides, I doubt our Canadian [...]





